📰 Listing News
Page 322 - Listing News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Listing. Real-time updates on events, politics, business and more.
February 7, 2023
With effect from February 08, 2023, the subscription rights in CirChem AB will be traded on First North Growth Market. Trading will continue up until and including February 17, 2023. Instrument: Subscription
February 7, 2023
DJ Cairn Homes Plc: Block listing Interim Review Cairn Homes Plc (CRN) Cairn Homes Plc: Block listing Interim Review 07-Feb-2023 / 15:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted
February 6, 2023
Hong Kong remains determined to convince Saudi Aramco to make its secondary listing on the Hong Kong stock exchange
February 6, 2023
Emmy-winning journalist Harris Faulkner provides the latest news with insightful analysis and interviews with top newsmakers.
February 3, 2023
Calgary, Alberta--(Newsfile Corp. - February 2, 2023) - Saturn Oil & Gas Inc. (TSXV: SOIL) (FSE: SMKA) ("Saturn" or the "Company") is pleased to announce that, further to the Company's January 31, 2023
February 3, 2023
Defunding these agencies that are out of control and cutting across the board cutting spending 10 percent a year like every american family like every business has already had to do. >> absolutely right, gentlemen thank you. great to see you. now how do you know that companies that virtue signal with diversity equity inclusion know its a scam? well theyre the first employees dei employees sent packing bloomberg reporting the lay offs sweeping the tech industry are gutting dei departments. listin...
February 3, 2023
Marula Mining Plc - Marula Mining Seeks Listing on AIM PR Newswire London, February 3 Marula Mining PLC ("Marula'' or the "Company") 3 February 2023 Marula
February 3, 2023
Chinas move this week to streamline stock market listing rules is unlikely to result in a flood of initial public offerings, bankers say, citing the prospect of state intervention on national... | February 3, 2023
February 3, 2023
Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of novel investigational therapeutics built on protein dysregulation expertise, today announced
February 2, 2023
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the compensation committee of KalVista's board of directors granted two newly-hired employees inducement options to purchase an aggregate